Pulmatrix logo

Pulmatrix

PULM | NASDAQ
Chart Builder DCF Calculator
$1.29
$0.00 (0.00%)
At close: Nov 16, 2026, 3:59 PM ET
$1.31
+$0.02 (+1.55%)
After-hours: Nov 16, 2026, 6:15 PM ET
+0.00%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
30.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #785/1021 (Top 77%)

Key Statistics

Market Data

Market Cap $4.71M
1D Range
1.25 1.39
52W Range
1.19 4.75

Valuation (TTM)

PE -1.17
PB 1.84
EV/EBITDA -0.63

Valuation (NTM)

Forward PE 2.62
Forward PEG 0.02
Price Target $0.00
Loading financial charts...

Profile

Pulmatrix, Inc. (PULM) is a clinical-stage biotechnology firm focused on creating and advancing inhaled treatments. The company's primary goal is to address significant unmet medical needs in respirat...

Sector Healthcare
Industry Biotechnology
Employees 2
IPO Date Mar 21, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Nov 16, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.